Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-111-9 | CAS number: 78-38-6
Toxicological information
Skin sensitisation
Currently viewing:
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- other: LuSens Test
- Justification for non-LLNA method:
- The LuSens test is an ARE Reporter Gene Assay that was developed by the BASF SE (Ludwigshafen, Germany) and is based on the OECD 442D Guideline (KeratinoSens As-say). The assay differs in some points from the OECD guideline.
Test material
- Reference substance name:
- Diethyl ethylphosphonate
- EC Number:
- 201-111-9
- EC Name:
- Diethyl ethylphosphonate
- Cas Number:
- 78-38-6
- Molecular formula:
- C6H15O3P
- IUPAC Name:
- diethyl phosphonate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Designation in Test Facility: 17080101G
Date of Receipt: 31. Jul. 2017
Condition at Receipt: Room temperature
6.1.1 Specification
The following information concerning identity and composition of the test item was provid-ed by the sponsor.
Name Diethyl ethylphosphonate
Batch no. 170635
Appearance colorless clear liquid
Composition Diethyl ethylphosphonate
Purity 96.5 %
Homogeneity homogeneous
Expiry date 18. Jun. 2019
Storage Room Temperature (20 ± 5°C)
The following information was provided by the sponsor as well:
CAS No. 78-38-6
EINECS-No. 201-111-9
Molecular formula C6H15O3P
Molecular weight 166.16 g/mol
Vapour pressure not stated
Stability H2O: 96h; EtOH: 96h; acetone: 96h; CH3CN: 96h; DMSO: 96h
Solubility H2O: unknown; EtOH: unknown; acetone: unknown; CH3CN: unknown; DMSO: unknown
Production date 19. Jun. 2017
In vitro test system
- Details on the study design:
- 6.3.1 Reasons for the Choice of the LuSens Cell Line
The LuSens cell line was specially designed for this test system by the BASF SE (Lud-wigshafen, Germany). It employs the use of a reporter gene for luciferase placed under the control of the antioxidant response element (ARE) and hence monitors Nrf-2 transcription factor activity. For designing this cell line, a human keratinocyte cell line (provided by RWTH, Aachen, Germany) was transfected with the pGL4.20 [luc2/Puro] vector (Promega, Germany) carrying the regulatory antioxidant response element (ARE) upstream of the luciferase gene (Luc2, Promega, Germany) at the Institute of Anatomy and Cell Biology of the RWTH, Aachen (laboratory of PD Dr. Wruck).
6.3.2 Cell Cultures
For mycoplasma contamination screened stocks of LuSens cells are stored in liquid nitro-gen in the cell bank of LAUS GmbH to allow a continuous stock of cells, which guarantees similar parameters of the experiment and reproducible characteristics of the cells.
For the Cytotoxicity Range Finder Assay cells of passage 7 were used. For the main ex-periments cells of passage 9 were used. After thawing the cells were cultivated in DMEM (9 % FCS) in cell culture flasks at 37 ± 1 °C in a humidified atmosphere with 5.0 ± 0.5 % CO2.
Results and discussion
In vitro / in chemico
Results
- Parameter:
- other: relative viability
- Value:
- 70
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- The average induction for the positive control should be ≥ 2.5 fold and it should have a rela-tive viability of at least 70 %.
The induction triggered by the negative control and growth control should be < 1.5 fold as compared to the induction of the solvent control and the viability should be above 70%.
The average percentage standard deviation (luciferase induction) of the variability in at least 21 solvent control wells should be below 20 %.
At least 3 test concentrations must be within viability limits, i.e. have relative viability of at least 70 %.
All validity criteria were met. Therefore, the study is valid.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
